Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Cancer survivor due for reauthorization in May
I was diagnosed in 1990 with follicular lymphoma.
It returned in 2003 and 2019 as DLBCL.
When it returned in 2019, I went through 4 different therapies over 2 years.
All failed to provide a complete remission.
The fifth treatment of Monjuvi and Revlimid worked.
I have been in remission for 2.5 years.
Following advise of my oncologist, I continue maintenance treatments of Monjuvi every 3 weeks.
In May, I am due for reauthorization for treatments.
Unfortunately, I do not trust my insurer.
In 2021, they approved Monjuvi, rescinded approval a few weeks later.
Fortunately, it was reversed under appeal.
Wished we had a better healthcare system in this country.